Viewing Study NCT00096434


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-02-01 @ 1:36 AM
Study NCT ID: NCT00096434
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2004-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib in Treating Patients With Metastatic Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Male Breast Cancer View
None Recurrent Breast Cancer View
None Stage IV Breast Cancer View
Keywords: